Neurovascular Dysfunction and Faulty Amyloid β-Peptide Clearance in Alzheimer Disease

Neurovascular dysfunction is an integral part of Alzheimer disease (AD). Changes in the brain vascular system may contribute in a significant way to the onset and progression of cognitive decline and the development of a chronic neurodegenerative process associated with accumulation of amyloid beta-peptide (A beta) in brain and cerebral vessels in AD individuals and AD animal models. Here, we review the role of the neurovascular unit and molecular mechanisms in cerebral vascular cells behind the pathogenesis of AD. In particular, we focus on blood-brain barrier (BBB) dysfunction, decreased cerebral blood flow, and impaired vascular clearance of Ab from brain. The data reviewed here support an essential role of the neurovascular and BBB mechanisms in AD pathogenesis.